A case of traditional herbal medicine-induced aristolochic acid nephropathy developing to end-stage renal failure

Japanese Journal of Nephrology

Volumn 47, Issue 4, 2005, Pages 474-480

  Fujimura, Toshiko ^a   Tamaki, Kiyoshi ^c   Iida, Shuji ^c   Tanaka, Hideharu ^c   Ikedou, Hirofumi ^c   Takamiya, Yoshimi ^c   Kato, Seiya ^a   Tanaka, Atsuo ^b   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI NAKATSU HOSPITAL   (Japan)

^c NONE

Author keywords

Aristolochic acid nephropathy; Chinese herbs nephropathy; End stage renal failure; Herbal medicine; Tubulointerstitial fibrosis

Indexed keywords

ARISTOLOCHIC ACID; CHINESE DRUG;

ADULT; ANEMIA; ARISTOLOCHIA; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; FANCONI RENOTUBULAR SYNDROME; HEMATURIA; HEMODIALYSIS; HERBAL MEDICINE; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERURICEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUBULE DISORDER; MALE; MUSCLE CRAMP; PROTEINURIA; RENAL DIABETES; TRADITIONAL MEDICINE; UREMIA; URINALYSIS;

ARISTOLOCHIC ACIDS; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; PHYTOTHERAPY; RENAL DIALYSIS;

EID: 21844433742     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-391.
2. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343: 174.
3. Tanaka A, Shinkai S, Kasuno K, Maeda K, Murata M, Seta K, Okuda J, Sugawara A, Yoshida T, Nishida R, Kuwahara T. Chinese herbs nephropathy in the Kansai area: a warning report. Nippon Jinzo Gakkai Shi 1997; 39: 438-440.
4. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL. Urothelial carcinoma associated with the use of a Chinese herb. N Engl J Med 2000; 342: 1686-1692.
5. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? Clin Nephrol 2000; 53: 301-306.
6. Yang SS, Chu P, Lin YF, Chen A, Lin SH. Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis. Am J Kidney Dis 2002; 39: E14.
7. Depierreux M, Van-Damme B, Vanden-Houte K, Vanherweghem JL. Pathological aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994; 24: 172-180.
8. Kanaan N, Cosyns JP, Jadoul M, Goffin E. The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency. Nephrol Dial Transplant 2003; 18: 440-442.
9. Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56: 2025-2028.
10. Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002; 17: 408-412.
11. Tanaka A, Nishida R, Yoshida T, Koshikawa M, Goto M, Kuwahara T. Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium? Intern Med 2001; 40: 290-300.
12. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 1996; 27: 209-215.
13. Chen HY, Ma BY, Grant A, Lampert N. Time to abandon the term "Chinese herbs nephropathy". Kidney Int 2001; 60: 2039-2040.
14. Cosyns JP, Dehoux JP, Guiot Y, Goebbels RM, Robert A, Bernard AM, van Ypersele de Strihou C. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001; 59: 2164-2173.
15. Solez K, Daugirdas J, Gregory MC, Frohnert PP, Bhowmik DM, Jha V, Cosyns JP. Is "Chinese herbs nephropathy" a prejudicial term? Am J Kidney Dis 2001; 38: 1141-1142.
16. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998; 339: 847.
17. Reginster F, Jadoul M, van Ypersele de Strihou C. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant 1997; 12: 81-86.
18. Lee CT, Wu MS, Lu K, Hsu KT. Renal tubular acidosis, hypokalemic paralysis, rhabdomyolysis, and acute renal failure - a rare presentation of Chinese herbal nephropathy. Ren Fail 1999; 21: 227-230.
19. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481-482.
20. Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000; 35: 313-318.
21. Nishimagi E, Kawaguchi Y, Terai C, Kajiyama H, Hara M, Kamatani N. Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome. Intern Med 2001; 40: 1059-1063.
22. Chang CH, Wang YM, Yang AH, Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001; 21: 441-448.
23. Li X, Yang L, Yu Y. An analysis of the clinical and pathological characteristics of mu-tong(a Chinese herb) induced tubulointerstitial nephropathy. Zhonghua Nei Ke Za Zhi 2001; 40: 681-687.
24. Krumme B, Endmeir R, Vanhaelen M, Walb D. Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid. Nephrol Dial Transplant 2001; 16: 400-402.
25. Chen W, Chen Y, Li A. The clinical and pathological manifestations of aristolochic acid nephropathy-the report of 58 cases. Zhonghua Yi Xue Za Zhi 2001; 81: 1101-1105.
26. Cronin AJ, Maidment G, Cook T, Kite GC, Simmonds MS, Pusey CD, Lord GM. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transplant 2002; 17: 524-525.
27. Yang L, Zhou X, Pang N, Chen W, Dong B, Chen YP, Zou WZ. Clinical analysis of two children with aristolochic acid nephropathy. Zhonghua Er Ke Za Zhi 2003; 41: 552-553.
28. Chan JS, Yang AH, Kao KP, Tarng DC. Acquired Fanconi syndrome induced by mixed Chinese herbs presenting as proximal muscle weakness. J Chin Med Assoc 2004; 67: 193-196.
29. Lo SH, Mo KL, Wong KS, Poon SP, Chan CK, Lai CK, Chan A. Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2004; 19: 1913-1915.
30. Lee S, Lee T, Lee B, Choi H, Yang M, Ihm CG, Kim K. Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology (Carlton) 2004; 9: 126-129.
31. Kazama I, Matsubara M, Michimata M, Suzuki M, Hatano R, Sato H, Ito S. Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy. Clin Exp Nephrol 2004; 8: 283-287.
32. Lo SH, Wong KS, Arlt VM, Phillips DH, Lai CK, Poon WT, Chan CK, Mo KL, Chan KW, Chan A. Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy. Am J Kidney Dis 2005; 45: 407-410.